These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


141 related items for PubMed ID: 8901020

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Kisspeptin regulates tuberoinfundibular dopaminergic neurones and prolactin secretion in an oestradiol-dependent manner in male and female rats.
    Ribeiro AB, Leite CM, Kalil B, Franci CR, Anselmo-Franci JA, Szawka RE.
    J Neuroendocrinol; 2015 Feb; 27(2):88-99. PubMed ID: 25453900
    [Abstract] [Full Text] [Related]

  • 25. Effects of sigma ligands on the ability of rimcazole to inhibit PCP hsp70 induction.
    Sharp JW, Williams DS.
    Brain Res Bull; 1996 Feb; 39(6):359-66. PubMed ID: 9138745
    [Abstract] [Full Text] [Related]

  • 26. [The effect of lithium treatment on the activity of central dopaminergic neurons].
    Koyama T.
    Hokkaido Igaku Zasshi; 1987 May; 62(3):402-16. PubMed ID: 3111963
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Neurochemical evidence that AMPA receptor-mediated tonic inhibition of hypothalamic dopaminergic neurons occurs via activation of inhibitory interneurons.
    Wagner EJ, Moore KE, Lookingland KJ.
    Brain Res; 1994 Oct 17; 660(2):319-22. PubMed ID: 7820700
    [Abstract] [Full Text] [Related]

  • 30. Comparison of the effects of remoxipride and raclopride on nigrostriatal and mesolimbic dopaminergic neuronal activity and on the secretion of prolactin and alpha-melanocyte-stimulating hormone.
    Eaton MJ, Tian Y, Lookingland KJ, Moore KE.
    Neuropsychopharmacology; 1992 Nov 17; 7(3):205-11. PubMed ID: 1326981
    [Abstract] [Full Text] [Related]

  • 31. Effects of the cocaine- and amphetamine-regulated transcript peptide on the turnover of dopamine in tuberoinfundibular neurons and serum prolactin levels: studies using estrogen, melanin concentrating hormone, and melanocortin.
    Yang SC, Shieh KR.
    Neuropharmacology; 2004 Dec 17; 47(7):1070-80. PubMed ID: 15555641
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effects of prolactin-releasing peptide on tuberoinfundibular dopaminergic neuronal activity and prolactin secretion in estrogen-treated female rats.
    Yuan ZF, Yang SC, Pan JT.
    J Biomed Sci; 2002 Dec 17; 9(2):112-8. PubMed ID: 11914577
    [Abstract] [Full Text] [Related]

  • 35. An endogenous serotonergic rhythm acting on 5-HT(2A) receptors may be involved in the diurnal changes in tuberoinfundibular dopaminergic neuronal activity and prolactin secretion in female rats.
    Liang SL, Pan JT.
    Neuroendocrinology; 2000 Jul 17; 72(1):11-9. PubMed ID: 10940734
    [Abstract] [Full Text] [Related]

  • 36. delta-Opioid receptor-mediated regulation of central dopaminergic neurons in the rat.
    Manzanares J, Durham RA, Lookingland KJ, Moore KE.
    Eur J Pharmacol; 1993 Nov 02; 249(1):107-12. PubMed ID: 8282012
    [Abstract] [Full Text] [Related]

  • 37. Kappa-opioid-receptor-mediated regulation of alpha-melanocyte-stimulating hormone secretion and tuberohypophyseal dopaminergic neuronal activity.
    Manzanares J, Lookingland KJ, Moore KE.
    Neuroendocrinology; 1990 Aug 02; 52(2):200-5. PubMed ID: 2177159
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Neurochemical evidence that estrogen-induced suppression of kappa-opioid-receptor-mediated regulation of tuberoinfundibular dopaminergic neurons is prolactin-independent.
    Wagner EJ, Manzanares J, Moore KE, Lookingland KJ.
    Neuroendocrinology; 1994 Mar 02; 59(3):197-201. PubMed ID: 7909142
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.